期刊文献+

非编码RNA在细胞自噬中的研究进展 被引量:7

Research Progress of Non-coding RNA in Autophagy
原文传递
导出
摘要 细胞自噬是细胞在应激条件下降解胞内受损成分的过程,涉及多信号分子参与。在疾病发生、发展过程中,细胞自噬既可抑制或延缓疾病发展,还可使病情恶化,故寻找在不同阶段调控细胞自噬作用的因子探究其有效作用靶点具有重要意义。非编码RNA(noncoding RNA,ncRNA)是从基因组中转录出来的不行使编码蛋白质作用的一类RNA的总称。进几年来,越来越多不同ncRNA被发现,并在动物机体生理和病理过程中发挥着重要的调控作用。已有研究表明,ncRNA在细胞自噬发生过程起到重要的调控作用。从微小RNA(MicroRNA,miRNA)、长链非编码RNA(Long noncoding RNAs,lncRNA)、环状RNA(CircularRNA,circRNA)几方面综述了ncRNA在细胞自噬通路中的调节作用,为癌症等疾病治疗以及分子标记提供理论指导和新思路。 Autophagy is a process in which cells degrade intracellular damaged components under stress conditions and involves the involvement of multiple signaling molecules. In the process of disease occurrence and development,autophagy can inhibit or delay the development of the disease,and can also make the disease worse. Therefore,it is of great significance to find the factors that regulate the autophagy at different stages to explore its effective target. Noncoding RNA( ncRNA) is a generic term for a class of RNA that is transcribed from the genome and does not travel to encode proteins. Over the years,more and more different ncRNAs have been discovered and play an important regulatory role in the physiological and pathological processes of animals. Studies have shown that ncRNA plays an important regulatory role in the process of autophagy. This article intends to review the regulation of ncRNA in the autophagy pathway from microRNAs( miRNAs),long noncoding RNAs( lncRNAs),circular RNAs( circRNAs),and to treat diseases such as cancer and Molecular markers provide theoretical guidance and new ideas.
作者 沈冰蕾 王宇轩 韩硕 李熹 杨卓妮娜 邹紫雯 刘娟 SHEN Bing-lei;WANG Yu-xuan;HAN Shuo;LI Xi;YANG Zhuo-ni-na;ZOU Zi-wen;LIU Juan(College of Animal Science,Heilongjiang Bayi Agricultural University,Daqing 163319,China)
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2019年第12期56-63,共8页 China Biotechnology
基金 中国博士后科学基金(2018M631970) 黑龙江省博士后启动基金(LBH-Z16166) 黑龙江省牛病防制重点实验室开放课题(PCBD201708)资助项目
关键词 细胞自噬 NCRNA MICRORNA lncRNA circRNA Autophagy ncRNA microRNA lncRNA circRNA
  • 相关文献

参考文献3

二级参考文献25

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献1053

同被引文献51

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部